ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Liposome Drug Delivery Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
Published Date: June 2025
|
Report Code: QYRE-Auto-21Z496
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Liposome Drug Delivery Market Insights and Forecast to 2028
BUY CHAPTERS

Global Liposome Drug Delivery Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

Code: QYRE-Auto-21Z496
Report
June 2025
Pages:147
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Gilead Sciences
Pacira
Sun Pharmaceutical
Johnson & Johnson
Luye Pharma
Sigma -Tau
Ipsen (Onivyde)
CSPC
Teva Pharmaceutical
Novartis
Fudan-Zhangjiang

Liposome Drug Delivery Market Size

In 2024, the global market size of Liposome Drug Delivery was estimated to be worth US$ 4742 million and is forecast to reach approximately US$ 10890 million by 2031 with a CAGR of 12.8% during the forecast period 2025-2031.

Liposome Drug Delivery Market

Liposome Drug Delivery Market

Liposomes have been used to improve the therapeutic index of new or established drugs by modifying drug absorption, reducing metabolism, prolonging biological half-life or reducing toxicity. Drug distribution is then controlled primarily by properties of the carrier and no longer by physico-chemical characteristics of the drug substance only. In a liposome drug product, the drug substance is contained in liposomes. Typically, water soluble drugs are contained in the aqueous compartment(s) and hydrophobic drugs are contained in the lipid layer(s) of the liposomes. Release of drugs from liposome formulations can be modified by the presence of polyethylene glycol and/or cholesterol or other potential additives in the liposome.
Global Liposome Drug Delivery key players include Gilead Sciences, Pacira, Sun Pharmaceutical, Johnson & Johnson, Luye Pharma, etc. Global top five manufacturers hold a share about 60%. North America is the largest market, with a share about 40%, followed by Europe and Asia-Pacific, both with a share about 30 percent. In terms of product, Liposomal Doxorubicin is the largest segment, with a share about 40%. And in terms of application, the largest application is Cancer & Tumor Therapy, followed by Fungal Infection Therapy, etc.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Liposome Drug Delivery, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Liposome Drug Delivery.
The Liposome Drug Delivery market size, estimations, and forecasts are provided in terms of sales volume (K Vial) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Liposome Drug Delivery market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Liposome Drug Delivery manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and regions.

Scope of Liposome Drug Delivery Market Report

Report Metric Details
Report Name Liposome Drug Delivery Market
Forecasted market size in 2031 approximately US$ 10890 million
CAGR 12.8%
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • Fungal Infection Therapy
  • Cancer & Tumor Therapy
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Gilead Sciences, Pacira, Sun Pharmaceutical, Johnson & Johnson, Luye Pharma, Sigma-Tau, Ipsen (Onivyde), CSPC, Teva Pharmaceutical, Novartis, Fudan-Zhangjiang
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Sales (consumption), revenue of Liposome Drug Delivery in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
  • Chapter 3: Detailed analysis of Liposome Drug Delivery manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Liposome Drug Delivery sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
  • Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
  • Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 14: Research Findings and Conclusion.

FAQ for this report

What is the Liposome Drug Delivery Market size in 2031?

Ans: The Liposome Drug Delivery Market size in 2031 will be approximately US$ 10890 million.

What is the market share of major companies in Liposome Drug Delivery Market?

Ans: Global top five manufacturers hold a share about 60%.

What is the Liposome Drug Delivery Market share by type?

Ans: In terms of product, Liposomal Doxorubicin is the largest segment, with a share about 40%.

Who are the main players in the Liposome Drug Delivery Market report?

Ans: The main players in the Liposome Drug Delivery Market are Gilead Sciences, Pacira, Sun Pharmaceutical, Johnson & Johnson, Luye Pharma, Sigma-Tau, Ipsen (Onivyde), CSPC, Teva Pharmaceutical, Novartis, Fudan-Zhangjiang

What are the Application segmentation covered in the Liposome Drug Delivery Market report?

Ans: The Applications covered in the Liposome Drug Delivery Market report are Fungal Infection Therapy, Cancer & Tumor Therapy, Others

What are the Type segmentation covered in the Liposome Drug Delivery Market report?

Ans: The Types covered in the Liposome Drug Delivery Market report are Liposomal Doxorubicin, Liposomal Amphoteracin B, Liposomal Paclitaxel, Others

Recommended Reports

Liposome Technology

Cancer Therapy Markets

Advanced Drug Delivery

1 Study Coverage
1.1 Liposome Drug Delivery Product Introduction
1.2 Market by Type
1.2.1 Global Liposome Drug Delivery Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Liposomal Doxorubicin
1.2.3 Liposomal Amphoteracin B
1.2.4 Liposomal Paclitaxel
1.2.5 Others
1.3 Market by Application
1.3.1 Global Liposome Drug Delivery Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Fungal Infection Therapy
1.3.3 Cancer & Tumor Therapy
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Liposome Drug Delivery Market Size Estimates and Forecasts
2.1.1 Global Liposome Drug Delivery Revenue 2020-2031
2.1.2 Global Liposome Drug Delivery Sales 2020-2031
2.2 Liposome Drug Delivery Market Size by Region: 2024 Versus 2031
2.3 Liposome Drug Delivery Sales by Region (2020-2031)
2.3.1 Global Liposome Drug Delivery Sales by Region: 2020-2025
2.3.2 Global Liposome Drug Delivery Sales Forecast by Region (2026-2031)
2.3.3 Global Liposome Drug Delivery Sales Market Share by Region (2020-2031)
2.4 Liposome Drug Delivery Market Estimates and Projections by Region (2026-2031)
2.4.1 Global Liposome Drug Delivery Revenue by Region: 2020-2025
2.4.2 Global Liposome Drug Delivery Revenue Forecast by Region (2026-2031)
2.4.3 Global Liposome Drug Delivery Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Liposome Drug Delivery Sales by Type (2020-2031)
3.1.1.1 Global Liposome Drug Delivery Sales Volume by Type (2020-2031)
3.1.1.2 Global Liposome Drug Delivery Sales Market Share by Type (2020-2031)
3.1.2 Global Liposome Drug Delivery Revenue by Type (2020-2031)
3.1.2.1 Global Liposome Drug Delivery Revenue by Type (2020-2031)
3.1.2.2 Global Liposome Drug Delivery Revenue Market Share by Type (2020-2031)
3.1.3 Liposome Drug Delivery Average Selling Price (ASP) by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Liposome Drug Delivery Sales by Application (2020-2031)
3.2.1.1 Global Liposome Drug Delivery Sales Volume by Application (2020-2031)
3.2.1.2 Global Liposome Drug Delivery Sales Market Share by Application (2020-2031)
3.2.2 Global Liposome Drug Delivery Revenue by Application (2020-2031)
3.2.2.1 Global Liposome Drug Delivery Revenue by Application (2020-2031)
3.2.2.2 Global Liposome Drug Delivery Revenue Market Share by Application (2020-2031)
3.2.3 Liposome Drug Delivery Average Selling Price (ASP) by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Liposomal Doxorubicin of Liposome Drug Delivery Revenue Market Share by Application
3.3.2 Liposomal Amphoteracin B of Liposome Drug Delivery Revenue Market Share by Application
3.3.3 Liposomal Paclitaxel of Liposome Drug Delivery Revenue Market Share by Application
3.3.4 Others of Liposome Drug Delivery Revenue Market Share by Application
4 Global Liposome Drug Delivery by Manufacturers
4.1 Global Top Liposome Drug Delivery Manufacturers by Sales (2020-2025)
4.1.1 Global Liposome Drug Delivery Sales by Manufacturer (2020-2025)
4.1.2 Global Liposome Drug Delivery Sales Market Share by Manufacturer (2020-2025)
4.2 Global Top Liposome Drug Delivery Manufacturers by Revenue (2020-2025)
4.2.1 Global Liposome Drug Delivery Revenue by Manufacturer (2020-2025)
4.2.2 Global Liposome Drug Delivery Revenue Share by Manufacturer (2020-2025)
4.3 Global Liposome Drug Delivery Price by Manufacturer (2020-2025)
4.4 Competitive Landscape
4.4.1 Key Liposome Drug Delivery Manufacturers Covered: Ranking by Revenue
4.4.2 Global Liposome Drug Delivery Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.4.3 Global Liposome Drug Delivery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5 Global Liposome Drug Delivery Manufacturing Base Distribution, Product Type
4.5.1 Liposome Drug Delivery Manufacturers Manufacturing Base Distribution, Headquarters
4.5.2 Date of International Manufacturers Enter into Liposome Drug Delivery Market
4.5.3 Manufacturers Liposome Drug Delivery Product Type and Application
4.5.4 Liposomal Doxorubicin Market Sales of Liposome Drug Delivery by Manufacturer
4.5.5 Liposomal Amphoteracin B Market Sales of Liposome Drug Delivery by Manufacturer
4.5.6 Liposomal Paclitaxel Market Sales of Liposome Drug Delivery by Manufacturer
4.5.7 Others Market Sales of Liposome Drug Delivery by Manufacturer
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Gilead Sciences
5.1.1 Gilead Sciences Company Information
5.1.2 Gilead Sciences Description, Business Overview
5.1.3 Gilead Sciences Liposome Drug Delivery Products Offered
5.1.4 Gilead Sciences Liposome Drug Delivery Sales, Revenue and Gross Margin (2020-2025)
5.1.5 Gilead Sciences Liposome Drug Delivery Sales by Product in 2024
5.1.6 Gilead Sciences Liposome Drug Delivery Sales by Application in 2024
5.1.7 Gilead Sciences Liposome Drug Delivery Sales by Geographic Area in 2024
5.1.8 Gilead Sciences Recent Developments
5.2 Pacira
5.2.1 Pacira Company Information
5.2.2 Pacira Description, Business Overview
5.2.3 Pacira Liposome Drug Delivery Products Offered
5.2.4 Pacira Liposome Drug Delivery Sales, Revenue and Gross Margin (2020-2025)
5.2.5 Pacira Liposome Drug Delivery Sales by Product in 2024
5.2.6 Pacira Liposome Drug Delivery Sales by Application in 2024
5.2.7 Pacira Liposome Drug Delivery Sales by Geographic Area in 2024
5.2.8 Pacira Recent Developments
5.3 Sun Pharmaceutical
5.3.1 Sun Pharmaceutical Company Information
5.3.2 Sun Pharmaceutical Description, Business Overview
5.3.3 Sun Pharmaceutical Liposome Drug Delivery Products Offered
5.3.4 Sun Pharmaceutical Liposome Drug Delivery Sales, Revenue and Gross Margin (2020-2025)
5.3.5 Sun Pharmaceutical Liposome Drug Delivery Sales by Product in 2024
5.3.6 Sun Pharmaceutical Liposome Drug Delivery Sales by Application in 2024
5.3.7 Sun Pharmaceutical Liposome Drug Delivery Sales by Geographic Area in 2024
5.3.8 Sun Pharmaceutical Recent Developments
5.4 Johnson & Johnson
5.4.1 Johnson & Johnson Company Information
5.4.2 Johnson & Johnson Description, Business Overview
5.4.3 Johnson & Johnson Liposome Drug Delivery Products Offered
5.4.4 Johnson & Johnson Liposome Drug Delivery Sales, Revenue and Gross Margin (2020-2025)
5.4.5 Johnson & Johnson Liposome Drug Delivery Sales by Product in 2024
5.4.6 Johnson & Johnson Liposome Drug Delivery Sales by Application in 2024
5.4.7 Johnson & Johnson Liposome Drug Delivery Sales by Geographic Area in 2024
5.4.8 Johnson & Johnson Recent Developments
5.5 Luye Pharma
5.5.1 Luye Pharma Company Information
5.5.2 Luye Pharma Description, Business Overview
5.5.3 Luye Pharma Liposome Drug Delivery Products Offered
5.5.4 Luye Pharma Liposome Drug Delivery Sales, Revenue and Gross Margin (2020-2025)
5.5.5 Luye Pharma Liposome Drug Delivery Sales by Product in 2024
5.5.6 Luye Pharma Liposome Drug Delivery Sales by Application in 2024
5.5.7 Luye Pharma Liposome Drug Delivery Sales by Geographic Area in 2024
5.5.8 Luye Pharma Recent Developments
5.6 Sigma-Tau
5.6.1 Sigma-Tau Company Information
5.6.2 Sigma-Tau Description, Business Overview
5.6.3 Sigma-Tau Liposome Drug Delivery Products Offered
5.6.4 Sigma-Tau Liposome Drug Delivery Sales, Revenue and Gross Margin (2020-2025)
5.6.5 Sigma-Tau Liposome Drug Delivery Sales by Product in 2024
5.6.6 Sigma-Tau Liposome Drug Delivery Sales by Application in 2024
5.6.7 Sigma-Tau Liposome Drug Delivery Sales by Geographic Area in 2024
5.6.8 Sigma-Tau Recent Developments
5.7 Ipsen (Onivyde)
5.7.1 Ipsen (Onivyde) Company Information
5.7.2 Ipsen (Onivyde) Description, Business Overview
5.7.3 Ipsen (Onivyde) Liposome Drug Delivery Products Offered
5.7.4 Ipsen (Onivyde) Liposome Drug Delivery Sales, Revenue and Gross Margin (2020-2025)
5.7.5 Ipsen (Onivyde) Liposome Drug Delivery Sales by Product in 2024
5.7.6 Ipsen (Onivyde) Liposome Drug Delivery Sales by Application in 2024
5.7.7 Ipsen (Onivyde) Liposome Drug Delivery Sales by Geographic Area in 2024
5.7.8 Ipsen (Onivyde) Recent Developments
5.8 CSPC
5.8.1 CSPC Company Information
5.8.2 CSPC Description, Business Overview
5.8.3 CSPC Liposome Drug Delivery Products Offered
5.8.4 CSPC Liposome Drug Delivery Sales, Revenue and Gross Margin (2020-2025)
5.8.5 CSPC Liposome Drug Delivery Sales by Product in 2024
5.8.6 CSPC Liposome Drug Delivery Sales by Application in 2024
5.8.7 CSPC Liposome Drug Delivery Sales by Geographic Area in 2024
5.8.8 CSPC Recent Developments
5.9 Teva Pharmaceutical
5.9.1 Teva Pharmaceutical Company Information
5.9.2 Teva Pharmaceutical Description, Business Overview
5.9.3 Teva Pharmaceutical Liposome Drug Delivery Products Offered
5.9.4 Teva Pharmaceutical Liposome Drug Delivery Sales, Revenue and Gross Margin (2020-2025)
5.9.5 Teva Pharmaceutical Liposome Drug Delivery Sales by Product in 2024
5.9.6 Teva Pharmaceutical Liposome Drug Delivery Sales by Application in 2024
5.9.7 Teva Pharmaceutical Liposome Drug Delivery Sales by Geographic Area in 2024
5.9.8 Teva Pharmaceutical Recent Developments
5.10 Novartis
5.10.1 Novartis Company Information
5.10.2 Novartis Description, Business Overview
5.10.3 Novartis Liposome Drug Delivery Products Offered
5.10.4 Novartis Liposome Drug Delivery Sales, Revenue and Gross Margin (2020-2025)
5.10.5 Novartis Liposome Drug Delivery Sales by Product in 2024
5.10.6 Novartis Liposome Drug Delivery Sales by Application in 2024
5.10.7 Novartis Liposome Drug Delivery Sales by Geographic Area in 2024
5.10.8 Novartis Recent Developments
5.11 Fudan-Zhangjiang
5.11.1 Fudan-Zhangjiang Company Information
5.11.2 Fudan-Zhangjiang Description, Business Overview
5.11.3 Fudan-Zhangjiang Liposome Drug Delivery Products Offered
5.11.4 Fudan-Zhangjiang Liposome Drug Delivery Sales, Revenue and Gross Margin (2020-2025)
5.11.5 Fudan-Zhangjiang Liposome Drug Delivery Sales by Product in 2024
5.11.6 Fudan-Zhangjiang Liposome Drug Delivery Sales by Application in 2024
5.11.7 Fudan-Zhangjiang Liposome Drug Delivery Sales by Geographic Area in 2024
5.11.8 Fudan-Zhangjiang Recent Developments
6 North America
6.1 North America Liposome Drug Delivery Market Size YoY Growth 2020-2031
6.2 North America Liposome Drug Delivery Market Facts & Figures by Country
6.2.1 North America Liposome Drug Delivery Sales by Country (2020-2031)
6.2.2 North America Liposome Drug Delivery Revenue by Country (2020-2031)
6.3 North America Liposome Drug Delivery Sales by Type (2020-2025)
6.4 North America Liposome Drug Delivery Sales by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Liposome Drug Delivery Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Liposome Drug Delivery Market Facts & Figures by Region
7.2.1 Asia-Pacific Liposome Drug Delivery Sales by Region (2020-2031)
7.2.2 Asia-Pacific Liposome Drug Delivery Revenue by Region (2020-2031)
7.3 Asia-Pacific Liposome Drug Delivery Sales by Type (2020-2025)
7.4 Asia-Pacific Liposome Drug Delivery Sales by Application (2020-2025)
8 Europe
8.1 Europe Liposome Drug Delivery Market Size YoY Growth 2020-2031
8.2 Europe Liposome Drug Delivery Market Facts & Figures by Country
8.2.1 Europe Liposome Drug Delivery Sales by Country (2020-2031)
8.2.2 Europe Liposome Drug Delivery Revenue by Country (2020-2031)
8.3 Europe Liposome Drug Delivery Sales by Type (2020-2025)
8.4 Europe Liposome Drug Delivery Sales by Application (2020-2025)
9 Latin America
9.1 Latin America Liposome Drug Delivery Market Size YoY Growth 2020-2031
9.2 Latin America Liposome Drug Delivery Market Facts & Figures by Country
9.2.1 Latin America Liposome Drug Delivery Sales by Country (2020-2031)
9.2.2 Latin America Liposome Drug Delivery Revenue by Country (2020-2031)
9.3 Latin America Liposome Drug Delivery Sales by Type (2020-2025)
9.4 Latin America Liposome Drug Delivery Sales by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Liposome Drug Delivery Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Liposome Drug Delivery Market Facts & Figures by Country
10.2.1 Middle East and Africa Liposome Drug Delivery Sales by Country (2020-2031)
10.2.2 Middle East and Africa Liposome Drug Delivery Revenue by Country (2020-2031)
10.3 Middle East and Africa Liposome Drug Delivery Sales by Type (2020-2025)
10.4 Middle East and Africa Liposome Drug Delivery Sales by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Liposome Drug Delivery Supply Chain Analysis
11.2 Liposome Drug Delivery Key Raw Materials and Upstream Suppliers
11.3 Liposome Drug Delivery Clients Analysis
11.4 Liposome Drug Delivery Sales Channel and Sales Model Analysis
11.4.1 Liposome Drug Delivery Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Liposome Drug Delivery Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Liposome Drug Delivery Distributors
12 Liposome Drug Delivery Market Dynamics
12.1 Liposome Drug Delivery Industry Trends
12.2 Liposome Drug Delivery Market Drivers
12.3 Liposome Drug Delivery Market Challenges
12.4 Liposome Drug Delivery Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
FEATURED COMPANIES
Gilead Sciences
Pacira
Sun Pharmaceutical
Johnson & Johnson
Luye Pharma
Sigma -Tau
Ipsen (Onivyde)
CSPC
Teva Pharmaceutical
Novartis
Fudan-Zhangjiang
List of Tables
 Table 1. Global Liposome Drug Delivery Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Global Liposome Drug Delivery Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 3. Global Liposome Drug Delivery Market Size by Region (US$ Million): 2024 VS 2031
 Table 4. Global Liposome Drug Delivery Sales by Region (2020-2025) & (K Vial)
 Table 5. Global Liposome Drug Delivery Sales Forecast by Region (2026-2031) & (K Vial)
 Table 6. Global Liposome Drug Delivery Revenue by Region (2020-2025) & (US$ Million)
 Table 7. Global Liposome Drug Delivery Revenue Forecast by Region (2026-2031) & (US$ Million)
 Table 8. Global Liposome Drug Delivery Sales Volume by Type (2020-2025) & (K Vial)
 Table 9. Global Liposome Drug Delivery Sales Volume by Type (2026-2031) & (K Vial)
 Table 10. Global Liposome Drug Delivery Revenue by Type (2020-2025) & (US$ Million)
 Table 11. Global Liposome Drug Delivery Revenue Forecast by Type (2026-2031) & (US$ Million)
 Table 12. Global Liposome Drug Delivery Sales Volume by Application (2020-2025) & (K Vial)
 Table 13. Global Liposome Drug Delivery Sales Volume by Application (2026-2031) & (K Vial)
 Table 14. Global Liposome Drug Delivery Revenue by Application (2020-2025) & (US$ Million)
 Table 15. Global Liposome Drug Delivery Revenue by Application (2026-2031) & (US$ Million)
 Table 16. Global Liposome Drug Delivery Sales by Manufacturer (2020-2025) & (K Vial)
 Table 17. Global Liposome Drug Delivery Sales Share by Manufacturer (2020-2025)
 Table 18. Liposome Drug Delivery Revenue by Manufacturer (2020-2025) & (US$ Million)
 Table 19. Liposome Drug Delivery Revenue Share by Manufacturer (2020-2025)
 Table 20. Key Manufacturers Liposome Drug Delivery Price (2020-2025) & (USD/Vial)
 Table 21. Ranking of Global Top Liposome Drug Delivery Manufacturers by Revenue (US$ Million) in 2024
 Table 22. Global Liposome Drug Delivery Manufacturers Market Concentration Ratio (CR5 and HHI) & (2020-2025)
 Table 23. Global Liposome Drug Delivery by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Liposome Drug Delivery as of 2024)
 Table 24. Liposome Drug Delivery Manufacturers Manufacturing Base Distribution and Headquarters
 Table 25. Date of International Manufacturers Enter into Liposome Drug Delivery Market
 Table 26. Manufacturers Liposome Drug Delivery Product Type and Application
 Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 28. Gilead Sciences Company Information
 Table 29. Gilead Sciences Description and Business Overview
 Table 30. Gilead Sciences Liposome Drug Delivery Product
 Table 31. Gilead Sciences Liposome Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2020-2025)
 Table 32. Gilead Sciences Sales Proportion of Liposome Drug Delivery by Product in 2024
 Table 33. Gilead Sciences Sales Proportion of Liposome Drug Delivery by Application in 2024
 Table 34. Gilead Sciences Sales Proportion of Liposome Drug Delivery by Geographic Area in 2024
 Table 35. Gilead Sciences Recent Developments
 Table 36. Pacira Company Information
 Table 37. Pacira Description and Business Overview
 Table 38. Pacira Liposome Drug Delivery Product
 Table 39. Pacira Liposome Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2020-2025)
 Table 40. Pacira Sales Proportion of Liposome Drug Delivery by Product in 2024
 Table 41. Pacira Sales Proportion of Liposome Drug Delivery by Application in 2024
 Table 42. Pacira Sales Proportion of Liposome Drug Delivery by Geographic Area in 2024
 Table 43. Pacira Recent Developments
 Table 44. Sun Pharmaceutical Company Information
 Table 45. Sun Pharmaceutical Description and Business Overview
 Table 46. Sun Pharmaceutical Liposome Drug Delivery Product
 Table 47. Sun Pharmaceutical Liposome Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2020-2025)
 Table 48. Sun Pharmaceutical Sales Proportion of Liposome Drug Delivery by Product in 2024
 Table 49. Sun Pharmaceutical Sales Proportion of Liposome Drug Delivery by Application in 2024
 Table 50. Sun Pharmaceutical Sales Proportion of Liposome Drug Delivery by Geographic Area in 2024
 Table 51. Sun Pharmaceutical Recent Developments
 Table 52. Johnson & Johnson Company Information
 Table 53. Johnson & Johnson Description and Business Overview
 Table 54. Johnson & Johnson Liposome Drug Delivery Product
 Table 55. Johnson & Johnson Liposome Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2020-2025)
 Table 56. Johnson & Johnson Sales Proportion of Liposome Drug Delivery by Product in 2024
 Table 57. Johnson & Johnson Sales Proportion of Liposome Drug Delivery by Application in 2024
 Table 58. Johnson & Johnson Sales Proportion of Liposome Drug Delivery by Geographic Area in 2024
 Table 59. Johnson & Johnson Recent Developments
 Table 60. Luye Pharma Company Information
 Table 61. Luye Pharma Description and Business Overview
 Table 62. Luye Pharma Liposome Drug Delivery Product
 Table 63. Luye Pharma Liposome Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2020-2025)
 Table 64. Luye Pharma Sales Proportion of Liposome Drug Delivery by Product in 2024
 Table 65. Luye Pharma Sales Proportion of Liposome Drug Delivery by Application in 2024
 Table 66. Luye Pharma Sales Proportion of Liposome Drug Delivery by Geographic Area in 2024
 Table 67. Luye Pharma Recent Developments
 Table 68. Sigma-Tau Company Information
 Table 69. Sigma-Tau Description and Business Overview
 Table 70. Sigma-Tau Liposome Drug Delivery Product
 Table 71. Sigma-Tau Liposome Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2020-2025)
 Table 72. Sigma-Tau Sales Proportion of Liposome Drug Delivery by Product in 2024
 Table 73. Sigma-Tau Sales Proportion of Liposome Drug Delivery by Application in 2024
 Table 74. Sigma-Tau Sales Proportion of Liposome Drug Delivery by Geographic Area in 2024
 Table 75. Sigma-Tau Recent Developments
 Table 76. Ipsen (Onivyde) Company Information
 Table 77. Ipsen (Onivyde) Description and Business Overview
 Table 78. Ipsen (Onivyde) Liposome Drug Delivery Product
 Table 79. Ipsen (Onivyde) Liposome Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2020-2025)
 Table 80. Ipsen (Onivyde) Sales Proportion of Liposome Drug Delivery by Product in 2024
 Table 81. Ipsen (Onivyde) Sales Proportion of Liposome Drug Delivery by Application in 2024
 Table 82. Ipsen (Onivyde) Sales Proportion of Liposome Drug Delivery by Geographic Area in 2024
 Table 83. Ipsen (Onivyde) Recent Developments
 Table 84. CSPC Company Information
 Table 85. CSPC Description and Business Overview
 Table 86. CSPC Liposome Drug Delivery Product
 Table 87. CSPC Liposome Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2020-2025)
 Table 88. CSPC Sales Proportion of Liposome Drug Delivery by Product in 2024
 Table 89. CSPC Sales Proportion of Liposome Drug Delivery by Application in 2024
 Table 90. CSPC Sales Proportion of Liposome Drug Delivery by Geographic Area in 2024
 Table 91. CSPC Recent Developments
 Table 92. Teva Pharmaceutical Company Information
 Table 93. Teva Pharmaceutical Description and Business Overview
 Table 94. Teva Pharmaceutical Liposome Drug Delivery Product
 Table 95. Teva Pharmaceutical Liposome Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2020-2025)
 Table 96. Teva Pharmaceutical Sales Proportion of Liposome Drug Delivery by Product in 2024
 Table 97. Teva Pharmaceutical Sales Proportion of Liposome Drug Delivery by Application in 2024
 Table 98. Teva Pharmaceutical Sales Proportion of Liposome Drug Delivery by Geographic Area in 2024
 Table 99. Teva Pharmaceutical Recent Developments
 Table 100. Novartis Company Information
 Table 101. Novartis Description and Business Overview
 Table 102. Novartis Liposome Drug Delivery Product
 Table 103. Novartis Liposome Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2020-2025)
 Table 104. Novartis Sales Proportion of Liposome Drug Delivery by Product in 2024
 Table 105. Novartis Sales Proportion of Liposome Drug Delivery by Application in 2024
 Table 106. Novartis Sales Proportion of Liposome Drug Delivery by Geographic Area in 2024
 Table 107. Novartis Recent Developments
 Table 108. Fudan-Zhangjiang Company Information
 Table 109. Fudan-Zhangjiang Description and Business Overview
 Table 110. Fudan-Zhangjiang Liposome Drug Delivery Product
 Table 111. Fudan-Zhangjiang Liposome Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2020-2025)
 Table 112. Fudan-Zhangjiang Sales Proportion of Liposome Drug Delivery by Product in 2024
 Table 113. Fudan-Zhangjiang Sales Proportion of Liposome Drug Delivery by Application in 2024
 Table 114. Fudan-Zhangjiang Sales Proportion of Liposome Drug Delivery by Geographic Area in 2024
 Table 115. Fudan-Zhangjiang Recent Developments
 Table 116. North America Liposome Drug Delivery Sales by Country (2020-2025) & (K Vial)
 Table 117. North America Liposome Drug Delivery Sales by Country (2026-2031) & (K Vial)
 Table 118. North America Liposome Drug Delivery Revenue by Country (2020-2025) & (US$ Million)
 Table 119. North America Liposome Drug Delivery Revenue by Country (2026-2031) & (US$ Million)
 Table 120. North America Liposome Drug Delivery Sales by Type (2020-2025) & (K Vial)
 Table 121. North America Liposome Drug Delivery Sales by Application (2020-2025) & (K Vial)
 Table 122. Asia-Pacific Liposome Drug Delivery Sales by Region (2020-2025) & (K Vial)
 Table 123. Asia-Pacific Liposome Drug Delivery Sales by Region (2026-2031) & (K Vial)
 Table 124. Asia-Pacific Liposome Drug Delivery Revenue by Region (2020-2025) & (US$ Million)
 Table 125. Asia-Pacific Liposome Drug Delivery Revenue by Region (2026-2031) & (US$ Million)
 Table 126. Asia-Pacific Liposome Drug Delivery Sales by Type (2020-2025) & (K Vial)
 Table 127. Asia-Pacific Liposome Drug Delivery Sales by Application (2020-2025) & (K Vial)
 Table 128. Europe Liposome Drug Delivery Sales by Country (2020-2025) & (K Vial)
 Table 129. Europe Liposome Drug Delivery Sales by Country (2026-2031) & (K Vial)
 Table 130. Europe Liposome Drug Delivery Revenue by Country (2020-2025) & (US$ Million)
 Table 131. Europe Liposome Drug Delivery Revenue by Country (2026-2031) & (US$ Million)
 Table 132. Europe Liposome Drug Delivery Sales by Type (2020-2025) & (K Vial)
 Table 133. Europe Liposome Drug Delivery Sales by Application (2020-2025) & (K Vial)
 Table 134. Latin America Liposome Drug Delivery Sales by Country (2020-2025) & (K Vial)
 Table 135. Latin America Liposome Drug Delivery Sales by Country (2026-2031) & (K Vial)
 Table 136. Latin America Liposome Drug Delivery Revenue by Country (2020-2025) & (US$ Million)
 Table 137. Latin America Liposome Drug Delivery Revenue by Country (2026-2031) & (US$ Million)
 Table 138. Latin America Liposome Drug Delivery Sales by Type (2020-2025) & (K Vial)
 Table 139. Latin America Liposome Drug Delivery Sales by Application (2020-2025) & (K Vial)
 Table 140. Middle East and Africa Liposome Drug Delivery Sales by Country (2020-2025) & (K Vial)
 Table 141. Middle East and Africa Liposome Drug Delivery Sales by Country (2026-2031) & (K Vial)
 Table 142. Middle East and Africa Liposome Drug Delivery Revenue by Country (2020-2025) & (US$ Million)
 Table 143. Middle East and Africa Liposome Drug Delivery Revenue by Country (2026-2031) & (US$ Million)
 Table 144. Middle East and Africa Liposome Drug Delivery Sales by Type (2020-2025) & (K Vial)
 Table 145. Middle East and Africa Liposome Drug Delivery Sales by Application (2020-2025) & (K Vial)
 Table 146. Liposome Drug Delivery Key Raw Materials, Industry Status and Trend
 Table 147. Liposome Drug Delivery Key Raw Materials and Upstream Suppliers
 Table 148. Liposome Drug Delivery Clients Status and Trend
 Table 149. Liposome Drug Delivery Typical Clients
 Table 150. Liposome Drug Delivery Distributors
 Table 151. Liposome Drug Delivery Market Trends
 Table 152. Liposome Drug Delivery Market Drivers
 Table 153. Liposome Drug Delivery Market Challenges
 Table 154. Liposome Drug Delivery Market Restraints
 Table 155. Research Programs/Design for This Report
 Table 156. Key Data Information from Secondary Sources
 Table 157. Key Data Information from Primary Sources
 Table 158. QYR Business Unit and Senior & Team Lead Analysts


List of Figures
 Figure 1. Liposome Drug Delivery Product Picture
 Figure 2. Global Liposome Drug Delivery Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
 Figure 3. Global Liposome Drug Delivery Sales Market Share by Type in 2024 & 2031
 Figure 4. Liposomal Doxorubicin Product Picture
 Figure 5. Liposomal Amphoteracin B Product Picture
 Figure 6. Liposomal Paclitaxel Product Picture
 Figure 7. Others Product Picture
 Figure 8. Global Liposome Drug Delivery Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
 Figure 9. Global Liposome Drug Delivery Sales Market Share by Application in 2024 & 2031
 Figure 10. Fungal Infection Therapy
 Figure 11. Cancer & Tumor Therapy
 Figure 12. Others
 Figure 13. Liposome Drug Delivery Report Years Considered
 Figure 14. Global Liposome Drug Delivery Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Liposome Drug Delivery Market Size 2020-2031 (US$ Million)
 Figure 16. Global Liposome Drug Delivery Sales 2020-2031 (K Vial)
 Figure 17. Global Liposome Drug Delivery Sales Market Share Forecast by Region (2020-2031)
 Figure 18. Global Liposome Drug Delivery Revenue Market Share by Region (2020-2031)
 Figure 19. Global Liposome Drug Delivery Sales Market Share Forecast by Type (2020-2031)
 Figure 20. Global Liposome Drug Delivery Revenue Market Share Forecast by Type (2020-2031)
 Figure 21. Liposome Drug Delivery Average Selling Price (ASP) by Type (2020-2025) & (USD/Vial)
 Figure 22. Global Liposome Drug Delivery Sales Market Share Forecast by Application (2020-2031)
 Figure 23. Global Liposome Drug Delivery Revenue Market Share Forecast by Application (2020-2031)
 Figure 24. Liposome Drug Delivery Average Selling Price (ASP) by Application (2020-2025) & (USD/Vial)
 Figure 25. Liposomal Doxorubicin of Liposome Drug Delivery Revenue Market Share by Application, 2024 VS 2031
 Figure 26. Liposomal Amphoteracin B of Liposome Drug Delivery Revenue Market Share by Application, 2024 VS 2031
 Figure 27. Liposomal Paclitaxel of Liposome Drug Delivery Revenue Market Share by Application, 2024 VS 2031
 Figure 28. Others of Liposome Drug Delivery Revenue Market Share by Application, 2024 VS 2031
 Figure 29. Global Liposome Drug Delivery Sales Share by Manufacturer in 2024
 Figure 30. Liposome Drug Delivery Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 31. Liposomal Doxorubicin Market Sales Proportion by Manufacturer in 2024
 Figure 32. Liposomal Amphoteracin B Market Sales Proportion by Manufacturer in 2024
 Figure 33. Liposomal Paclitaxel Market Sales Proportion by Manufacturer in 2024
 Figure 34. Others Market Sales Proportion by Manufacturer in 2024
 Figure 35. North America Liposome Drug Delivery Revenue 2020-2031 (US$ Million)
 Figure 36. North America Liposome Drug Delivery Sales Market Share by Type (2020-2025)
 Figure 37. North America Liposome Drug Delivery Sales Market Share by Application (2020-2025)
 Figure 38. Asia-Pacific Liposome Drug Delivery Revenue 2020-2031 (US$ Million)
 Figure 39. Asia-Pacific Liposome Drug Delivery Sales Market Share by Region (2020-2031)
 Figure 40. Asia-Pacific Liposome Drug Delivery Revenue Market Share by Region (2020-2031)
 Figure 41. Asia-Pacific Liposome Drug Delivery Sales Market Share by Type (2020-2025)
 Figure 42. Asia-Pacific Liposome Drug Delivery Sales Market Share by Application (2020-2025)
 Figure 43. Europe Liposome Drug Delivery Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 44. Europe Liposome Drug Delivery Sales Market Share by Country (2020-2031)
 Figure 45. Europe Liposome Drug Delivery Revenue Market Share by Country (2020-2031)
 Figure 46. Europe Liposome Drug Delivery Sales Market Share by Type (2020-2025)
 Figure 47. Europe Liposome Drug Delivery Sales Market Share by Application (2020-2025)
 Figure 48. Latin America Liposome Drug Delivery Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 49. Latin America Liposome Drug Delivery Sales Market Share by Country (2020-2031)
 Figure 50. Latin America Liposome Drug Delivery Revenue Market Share by Country (2020-2025)
 Figure 51. Latin America Liposome Drug Delivery Sales Market Share by Type (2020-2025)
 Figure 52. Latin America Liposome Drug Delivery Sales Market Share by Application (2020-2025)
 Figure 53. Middle East and Africa Liposome Drug Delivery Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 54. Middle East and Africa Liposome Drug Delivery Sales Market Share by Country (2020-2031)
 Figure 55. Middle East and Africa Liposome Drug Delivery Revenue Market Share by Country (2020-2031)
 Figure 56. Middle East and Africa Liposome Drug Delivery Sales Market Share by Type (2020-2025)
 Figure 57. Middle East and Africa Liposome Drug Delivery Sales Market Share by Application (2020-2025)
 Figure 58. Liposome Drug Delivery Supply Chain (Upstream and Downstream Market)
 Figure 59. Global Production Market Share of Liposome Drug Delivery Raw Materials by Region in 2024
 Figure 60. Liposome Drug Delivery Distribution Channels
 Figure 61. Global Liposome Drug Delivery Percentage 2020-2031: Indirect Sales VS Direct Sales
 Figure 62. Global Liposome Drug Delivery Percentage 2020-2031: Online Sales VS Offline Sales
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$5900

This license allows only one user to access the PDF.
Electronic (PDF)

$8850

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$11800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS

Global Liposome Assisted Drug Delivery Market Insights Forecast to 2030
Liposomal Drug delivery System Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Liposomal Market Insights Forecast to 2030
Global Liposome Injection Market Research Report 2025
Liposomes Nanocarrier Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Liposome and Lipid Nanoparticle Finished Pharmaceuticals Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Liposome Finished Pharmaceuticals Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Liposomal and Lipid based Nanoparticle Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Liposomal based Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Liposomes Nanoparticle Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Microsphere Liposomes Market Research Report 2024
Liposomal and Lipid Drug Delivery Systems Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Liposome Development Service Market Research Report 2025
Global Liposome Microsphere Market Research Report 2024
Liposome for Cosmetics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Liposome for Cosmetic Ingredients Market Research Report 2025
Global liposomes in Skin Care Market Research Report 2025
Liposomes for Cosmetics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Lipid Contract Manufacturing Market Research Report 2024
Liposome and Lipid Nanoparticle FDF Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions